峰瑞资本
@author-1781068851320
Why We're Bullish on Optical Chips | FreeS Fund Chip Series
What unexpected challenges do chip startups face?
How Should Brands Go Overseas on TikTok and With Independent Sites? | FreeS Fund Going Global Series
Do China's hard-won lessons from domestic competition still carry weight abroad?
Women Rising: 18 Voices from the World of Entrepreneurship | FreeS Fund International Women's Day Special
The traits that lead to success know no gender. May your journey of discovery be filled with wonder.
Is Home Maintenance and Renovation a Good Business Under the "Housing Is for Living In, Not Speculation" Policy? | FreeS Fund Interview
Delivery is core; digitalization is the future.
How to Build a Global Cross-Border E-Commerce Brand? | FreeS Fund Going Global Series
Can cross-border e-commerce players still win everywhere with the "value for money" playbook alone?
What Will Happen to Cross-Border E-Commerce in 2022? | FreeS Fund's Going Global Series
Why has cross-border e-commerce managed to buck the trend, and who will emerge as the next winners?
4 Companies Raise Nearly 2 Billion RMB in Total | FreeS Family Funding News · Vol 8
Walk alongside more outstanding founders.
Farewell to a Year of Inflection Points: Will 2022 Be Better? | Li Feng's New Year Outlook
Where the heart leads, steady steps take you far.
Our Year: Working Together, Staying the Course | FreeS Fund 2021 Year in Review
Walk alongside more outstanding founders.
Synthetic Biology: The *Heavenly Crafts* of the Next Twenty Years | 2021 FreeS Fund Annual Investor Summit
How will the convergence of biotechnology and data science transform the production methods for over 60% of the world's physical goods?
Li Xiang, Founder of Shize Biotech: The Latest Intersection in Biotechnology — The Spring of Stem Cell Therapy | 2021 FreeS Fund Annual Investor Summit
How much longer until stem cell therapy brings hope to patients with serious diseases?
How Does Single-Cell Sequencing Help You Understand the 40 Trillion Cells in Your Body? | 2021 FreeS Fund Annual Investor Summit
How Single-Cell Sequencing Is Revolutionizing Biomedicine